Literature DB >> 28092939

For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases.

Qibing Zhou1, Yushuang Wei1.   

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) have recently been used as an effective magnetic resonance imaging (MRI) contrast agent for the noninvasive diagnosis of chronic liver diseases including nonalcohol fatty liver diseases, nonalcohol steatohepatitis, and cirrhosis as well as liver tumors. However, the potential risk of the iron overload by SPIONs has been highly underestimated in chronic liver diseases. While most of SPIONs have been shown safe in the healthy group, significant toxicity potential by the iron overload has been revealed through immunotoxicity, lipid peroxidation, and fatty acid and cholesterol metabolism in cirrhosis as a high risk factor. As a result, the systems toxicology assessments of SPIONs are crucial in both healthy ones and chronic liver disease models to determine the margin of safety. In addition, the challenge of the iron overload by SPIONs requires better designed SPIONs as MRI contrast agents for chronic liver diseases such as the biodegradable nanocluster assembly with urine clearance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28092939     DOI: 10.1021/acs.chemrestox.6b00298

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  Controlling the Movement of Magnetic Iron Oxide Nanoparticles Intended for Targeted Delivery of Cytostatics.

Authors:  Yana Toropova; Dmitry Korolev; Maria Istomina; Galina Shulmeyster; Alexey Petukhov; Vladimir Mishanin; Andrey Gorshkov; Ekaterina Podyacheva; Kamil Gareev; Alexei Bagrov; Oleg Demidov
Journal:  Int J Nanomedicine       Date:  2021-08-20

2.  Toxicological Profiling of Metal Oxide Nanoparticles in Liver Context Reveals Pyroptosis in Kupffer Cells and Macrophages versus Apoptosis in Hepatocytes.

Authors:  Vahid Mirshafiee; Bingbing Sun; Chong Hyun Chang; Yu-Pei Liao; Wen Jiang; Jinhong Jiang; Xiangsheng Liu; Xiang Wang; Tian Xia; André E Nel
Journal:  ACS Nano       Date:  2018-03-19       Impact factor: 15.881

3.  Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment.

Authors:  Meijia Wu; Shengwu Huang
Journal:  Mol Clin Oncol       Date:  2017-08-28

4.  Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations.

Authors:  Tao Wen; Lifan Du; Bo Chen; Doudou Yan; Aiyun Yang; Jian Liu; Ning Gu; Jie Meng; Haiyan Xu
Journal:  Part Fibre Toxicol       Date:  2019-07-12       Impact factor: 9.400

5.  Evaluation of non-targeting, C- or N-pH (low) insertion peptide modified superparamagnetic iron oxide nanoclusters for selective MRI of liver tumors and their potential toxicity in cirrhosis.

Authors:  Abdulrahman Ahmed Mahmood; Jianqi Zhang; Rufang Liao; Xiwei Pan; Dan Xu; Haibo Xu; Qibing Zhou
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 4.036

Review 6.  Pharmacokinetics of magnetic iron oxide nanoparticles for medical applications.

Authors:  Julia Nowak-Jary; Beata Machnicka
Journal:  J Nanobiotechnology       Date:  2022-06-27       Impact factor: 9.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.